Home › Duchenne Muscular Dystrophy › North Carolina › Durham
Duchenne Muscular Dystrophy clinical trials in Durham, NC
5 studies for Duchenne Muscular Dystrophy are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
RecruitingPhase 1
- Duke University Medical Center, Durham
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
RecruitingObservational study
- Duke Children's Hospital, Durham
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
RecruitingObservational study
- Duke University / Lenox Baker Children's Hospital, Durham
Duchenne Electronic Health Record Study
RecruitingObservational study
- Duke University Medical Center, Durham
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
RecruitingPhase 3
- Rare Disease Research, LLC, Hillsborough · 13 mi away
Duchenne Muscular Dystrophy trials in other cities
- Little Rock, AR7 studies
- Sacramento, CA5 studies
- Chicago, IL5 studies
- Washington, DC5 studies
- Gainesville, FL5 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Columbus, OH4 studies
- Seattle, WA3 studies
- Mountain View, CA3 studies
- Norfolk, VA3 studies
- St. Louis, MO3 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.